Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Urinary arsenic levels and risk of renal injury in a cross-sectional study in open population.

Robles-Osorio ML, Pérez-Maldonado IN, Martín del Campo D, Montero-Perea D, Avilés-Romo I, Sabath-Silva E, Sabath E.

Rev Invest Clin. 2012 Nov-Dec;64(6 Pt 2):609-14.

PMID:
23593778
2.

alpha-1-Microglobulin: epidemiological indicator for tubular dysfunction induced by cadmium?

Pless-Mulloli T, Boettcher M, Steiner M, Berger J.

Occup Environ Med. 1998 Jul;55(7):440-5.

3.

Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore.

Hong CY, Hughes K, Chia KS, Ng V, Ling SL.

Diabetes Care. 2003 Feb;26(2):338-42.

PMID:
12547859
4.

Study of kidney dysfunction in non-silicotic Egyptian workers.

Ibrahim KS, Ahmed SB, Amer NM.

Int J Hyg Environ Health. 2011 Jan;214(1):53-8. doi: 10.1016/j.ijheh.2010.08.012.

PMID:
20851677
5.

Is the urinary biomarkers assessment a non-invasive approach to tubular lesions of the solitary kidney?

Gadalean F, Kaycsa A, Gluhovschi G, Velciov S, Gluhovschi C, Bob F, Bozdog G, Petrica L.

Ren Fail. 2013;35(10):1358-64. doi: 10.3109/0886022X.2013.828367.

PMID:
23992109
6.

The association between total urinary arsenic concentration and renal dysfunction in a community-based population from central Taiwan.

Chen JW, Chen HY, Li WF, Liou SH, Chen CJ, Wu JH, Wang SL.

Chemosphere. 2011 Jun;84(1):17-24. doi: 10.1016/j.chemosphere.2011.02.091.

PMID:
21458841
7.
8.

[Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method].

Hong F, Jin TY, Zhang AH.

Zhonghua Yu Fang Yi Xue Za Zhi. 2004 Nov;38(6):374-8. Chinese.

PMID:
15569507
9.

Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.

Hall AM, Edwards SG, Lapsley M, Connolly JO, Chetty K, O'Farrell S, Unwin RJ, Williams IG.

Am J Kidney Dis. 2009 Dec;54(6):1034-42. doi: 10.1053/j.ajkd.2009.07.012.

PMID:
19783343
10.

Comparative evaluation of four urinary tubular dysfunction markers, with special references to the effects of aging and correction for creatinine concentration.

Moriguchi J, Ezaki T, Tsukahara T, Furuki K, Fukui Y, Okamoto S, Ukai H, Sakurai H, Shimbo S, Ikeda M.

Toxicol Lett. 2003 Aug 28;143(3):279-90.

PMID:
12849688
11.

Risk factors for increased urinary inorganic arsenic concentrations from low arsenic concentrations in drinking water.

Hinwood AL, Sim MR, Jolley D, de Klerk N, Bastone EB, Gerostamoulos J, Drummer OH.

Int J Environ Health Res. 2003 Sep;13(3):271-84.

PMID:
12909558
12.

Tubular dysfunction and microalbuminuria in insulin dependent diabetes.

Walton C, Bodansky HJ, Wales JK, Forbes MA, Cooper EH.

Arch Dis Child. 1988 Mar;63(3):244-9.

13.

Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption.

Hollevoet K, Speeckaert MM, Decavele AS, Vanholder R, van Meerbeeck JP, Delanghe JR.

Clin Lung Cancer. 2012 Nov;13(6):470-4. doi: 10.1016/j.cllc.2011.12.004.

PMID:
22386954
14.

[Selected markers of subclinical renal damage in men occupationally exposed to mercury vapours].

Rutowski J, Moszczyński P.

Przegl Lek. 2006;63 Suppl 7:65-73. Polish.

PMID:
17784548
15.

Urinary mercury and biomarkers of early renal dysfunction in environmentally and occupationally exposed adults: a three-country study.

Jarosińska D, Horvat M, Sällsten G, Mazzolai B, Dabkowska B, Prokopowicz A, Biesiada M, Barregård L.

Environ Res. 2008 Oct;108(2):224-32. doi: 10.1016/j.envres.2008.06.005.

PMID:
18684440
16.

Environmental Arsenic Exposure and Urinary 8-OHdG in Arizona and Sonora.

Burgess JL, Meza MM, Josyula AB, Poplin GS, Kopplin MJ, McClellen HE, Stürup S, Lantz RC.

Clin Toxicol (Phila). 2007 Jun-Aug;45(5):490-8.

PMID:
17503254
17.
18.

Biomarkers of cadmium and arsenic interactions.

Nordberg GF, Jin T, Hong F, Zhang A, Buchet JP, Bernard A.

Toxicol Appl Pharmacol. 2005 Aug 7;206(2):191-7.

PMID:
15967208
19.

Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy.

Fraser JS, Muller AF, Smith DJ, Newman DJ, Lamb EJ.

Aliment Pharmacol Ther. 2001 Aug;15(8):1131-7.

20.

Biomarkers in assessing tubular lesions of the solitary kidney. The solitary kidney in special conditions.

Gluhovschi GH, Gadalean F, Gluhovschi C, Velciov S, Petrica L, Timar R, Anastasiu D, Gluhovschi A.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):135-42. Review.

PMID:
24620625

Supplemental Content

Support Center